Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)A Study of MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression
Phase 2
Terminated
- Conditions
- PsychosisDementiaAggressionAgitationAlzheimer Dementia
- Interventions
- Drug: Placebo
- First Posted Date
- 2017-02-06
- Last Posted Date
- 2021-04-01
- Lead Sponsor
- Mediti Pharma Inc.
- Target Recruit Count
- 81
- Registration Number
- NCT03044249
- Locations
- 🇺🇸
Dignity Health (St. Joseph Hospital and Medical Center), Phoenix, Arizona, United States
🇺🇸Neuro-Therapeutics Inc, Pasadena, California, United States
🇺🇸Associated Neurologists of Southern CT, Fairfield, Connecticut, United States
News
No news found